Neurochemical evidence that postsynaptic nucleus accumbens D3 receptor stimulation enhances cocaine reinforcement

Journal of Neurochemistry

Volumn 67, Issue 3, 1996, Pages 1078-1089

  Parsons, L H ^a   Caine, S B ^a   Sokoloff, P ^b   Schwartz, J C ^b   Koob, G F ^a   Weiss, F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CENTRE PAUL BROCA   (France)

Author keywords

7 Hydroxydipropylaminotetralin; Dopamine; Microdialysis; Nafadotride; Quinelorane; S elf administration

Indexed keywords

2 DIPROPYLAMINO 7 HYDROXYTETRALIN; COCAINE; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; QUINELORANE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; DRUG ABUSE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

ANIMALIA;

EID: 0029799757     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67031078.x     Document Type: Article

References (84)

1. Ahlenius S. and Salmi P. (1994) Behavioral and biochemical effects of the dopamine D3 receptor-selective ligand, 7-OH-DPAT, in the normal and reserpine-treated rat. Eur. J. Pharmacol. 260, 177-181.
2. + -evoked dopamine release in the neostriatum. Dev. Brain Res. 78, 123-130.
3. Bergman J., Kamien J. B., and Spealman R. D. (1990) Antagonism of cocaine self-administration by selective dopamine D1 and D2 antagonists. Behav. Pharmacol. 1, 355-363.
4. Booth R. G., Baldessarini R. J., Marsh E., and Owens C. E. (1994) Actions of (±) -7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain. Brain Res. 662, 283-288.
5. 125I]-iodosulpiride. Synapse 19, 1-13.
6. Bouthenet M. L., Souil R., Martres M. P., Sokoloff P., Giros B., and Schwartz J.-C. (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564, 203-219.
7. Britton D. R., Curzon P., Mackenzie R. G., Kebabian J. W., Williams J. E. G., and Kerkman D. (1991) Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration. Pharmacol. Biochem. Behav. 39, 911-915.
8. Burris K. D., Pacheca M. A., Filtz T. M., Kung M.-P., Kung H. F., and Molinoff P. B. (1995) Lack of discrimination by agonists for D2 and D3 dopamine receptors. Neuropsychopharmacology 12, 335-345.
9. Caine S. B. and Koob G. F. (1993) Modulation of cocaine self-administration in the rat through D3 dopamine receptors. Science 260, 1814-1816.
10. Caine S. B. and Koob G. F. (1994a) Effects of mesolimbic dopamine depletion on responding maintained by cocaine and food. J. Exp. Anal. Behav. 61, 213-221.
11. Caine S. B. and Koob G. F. (1994b) Effects of dopamine D1 and D2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270, 209-218.
12. Caine S. B. and Koob G. F. (1995) Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under difference schedules in the rat. Behav. Pharmacol. 6, 333-347.
13. Caine S. B., Lintz R., and Koob G. F. (1993) Intravenous drug self-administration techniques in animals, in Behavioral Neuroscience: A Practical Approach (Sahgal A., ed), pp. 117-143. Oxford University Press, Oxford.
14. Caine S. B., Heinrichs S. C., Coffin V. L., and Koob G. F. (1995) Effects of the dopamine D-1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Res. 692, 47-56.
15. Callahan P. M., Piercey M. F., and Cunningham K. A. (1992) Effects of the putative dopamine autoreceptor antagonists (+)-AJ76 and (+)-UH232 on the discriminative stimulus properties of cocaine. Psychopharmacology 107, 73-77.
16. Chapman M. A., See R. E., and Bissette G. (1992) Neurotensin increases extracellular striatal dopamine levels in vivo. Neuropeptides 22, 175-183.
17. Civelli O., Bunzow J. R., and Grandy D. K. (1993) Molecular diversity of dopamine receptors. Annu. Rev. Pharmacol. Toxicol. 33, 281-307.
18. Corrigall W. A. and Coen K. M. (1991) Cocaine self-administration is increased by both D1 and D2 antagonists. Pharmacol. Biochem. Behav. 39, 799-802.
19. Diaz J., Lévesque D., Griffon N., Lammers C. H., Martres M. P., Sokoloff P., and Schwartz J.-C. (1994) Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur, J. Neurosci. 6, 1384-1387.
20. Diaz J., Lévesque D., Lammers C. H., Griffon N., Martres M. P., Schwartz J.-C., and Sokoloff P. (1995) Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain. Neuroscience 65, 731-745.
21. Emmett-Oglesby M. W. and Lane J. D. (1992) Tolerance to the reinforcing effects of cocaine. Behav. Pharmacol. 3, 193-200.
22. Ervin G. N. and Nemeroff C. B. (1988) Antagonization of the behavioral activation produced by direct stimulation of forebrain dopamine receptors caused by intraacumbens injections of neurotensin. Neuropsychopharmacology 1, 243-250.
23. Ervin G. N., Birkemo L. S., Nemeroff C. B., and Prange A. J. (1981) Neurotensin blocks certain amphetamine-induced behaviors. Nature 291, 73-76.
24. Feenstra M. G. P., Sumners C., Goedemoed J. H., de Vries J. B., Rollema H., and Horn A. S. (1983) A comparison of the potencies of various dopamine receptor agonists in models for preand postsynaptic activity. Naunyn Schmiedebergs Arch. Pharmacol. 324, 108-115.
25. 3H]quinpirole binding sites in the rat brain. Synapse 14, 113-120.
26. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
27. 3H-Dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Life Sci. 30, 1587-1595.
28. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Brain Res. 648, 222-228.
29. Horger B. A., Taylor J. R., Elsworth J. D., and Roth R. H. (1994) Preexposure to, but not cotreatment with, the neurotensin antagonist SR 48692 delays the development of cocaine sensitization. Neuropsychopharmacology 11, 215-222.
30. Hubner C. B. and Koob G. F. (1990) Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychophamacology 3, 101-108.
31. Hubner C. B. and Moreton J. E. (1991) Effects of selective D1 and D2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105, 151-156.
32. Kling-Petersen T., Ljung E., and Svensson K. (1994) The preferential dopamine autoreceptor antagonist (+) - UH232 antagonizes the positive reinforcing effects of cocaine and d-amphetamine in the ICSS paradigm. Pharmacol. Biochem. Behav. 49, 345-351.
33. Koe B. K. (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J. Pharmacol. Exp. Ther. 199, 649-661.
34. Koob G. F. (1992a) Dopamine, addiction and reward. Semin. Neurosci. 4, 139-148.
35. Koob G. F. (1992b) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13, 177-184.
36. Koob G. F., Le H. T., and Creese I. (1987) The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79, 315-320.
37. Landwehrmeyer B., Mengod F., and Palacios J. M. (1993) Differential visualization of dopamine D2 and D3 receptor sites in rat brain: a comparative study using in situ hybridization histochemistry and ligand binding autoradiography. Eur. J. Neurosci. 5, 145-153.
38. Large C. H. and Stubbs M. (1994) The dopamine D3 receptor: Chinese hamsters or Chinese Whispers? Trends Pharmacol. Sci. 15, 46-47.
39. Larson E. R. and Ariano M. A. (1995) D3 and D2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse 20, 325-337.
40. 3H]-Quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. J. Pharmacol. Exp. Ther. 264, 991-1001.
41. 3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. USA 89, 8155-8159.
42. Lindvall O. and Bjorklund A. (1974) The organization of the ascending catecholaminergic neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. Suppl. 412, 1-48.
43. Liu J.-C., Cox R. F., Greif G. J., Freedman J. E., and Waszczak B. L. (1994) The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity. Eur. J. Pharmacol. 264, 269-278.
44. Maldonado R., Robledo P., Chover A. J., Caine S. B., and Koob G. F. (1993) D-1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat. Pharmacol. Biochem. Behav. 45, 239-242.
45. Mallet P. E. and Beninger R. J. (1994) 7-OH-DPAT produces place conditioning in rats. Eur. J. Pharmacol. 261, R5-R6.
46. Mansour A., Meador-Woodruff J. H., Zhou Q., Civelli O., Akil H., and Watson S. J. (1991) A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques. Neuroscience 45, 359-371.
47. Meller E., Bohmaker K., Goldstein M., and Basham D. A. (1993) Evidence that striatal synthesis-inhibiting autoreceptors are dopamine D3 receptors. Eur. J. Pharmacol. 249, R5-R6.
48. Moore R. Y. and Bloom F. E. (1978) Central catecholamine neuron systems: anatomy and physiology of the dopamine systems. Annu. Rev. Neurosci. 1, 129-169.
49. Morrison P. R., Bungay P. M., Hsiao J. K., Ball B. A., Mefford I. N., and Dedrick R. L. (1991) Quantitative microdialysis: analysis of transients and application to pharmacokinetics in brain. J. Neurochem. 57, 103-119.
50. Panagis G., Miligressis E., Anagnostakis Y., and Spyraki C. (1995) Ventral pallidum self-stimulation: a moveable electrode mapping study. Behav. Brain Res. 68, 165-172.
51. Parsons L. H. and Justice J. B. Jr. (1992) Extracellular concentration and in vivo recovery of dopamine in the nucleus accumbens using microdialysis. J. Neurochem. 58, 212-218.
52. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edit. Academic Press, San Diego.
53. Pettit H. O. and Justice J. B. Jr. (1991) Effect of dose on cocaine self-administration behavior and dopamine levels in the nucleus accumbens. Brain Res. 539, 94-102.
54. Phillips A. G., Broekkamp C. L., and Fibiger H. C. (1983) Strategies for studying the neurochemical substrates of drug reinforcement in rodents. Prog. Neuropsychopharmacol. Biol. Psychiatry 7, 585-590.
55. Piercey M. F., Lum J. T., Hoffman W. E., Carlsson A., Ljung E., and Svensson K. (1992) Antagonism of cocaine's pharmacological effects by the stimulant dopaminergic antagonists, (+)-AJ76 and (+)-UH232. Brain Res. 588, 217-222.
56. Richardson N. R., Piercey M. F., Svensson K., Collins R. J., Myers J. E., and Roberts D. C. S. (1993) Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist, (+)-AJ76. Brain Res. 619, 15-21.
57. Ritz M. C., Lam R. J., Goldberg S. R., and Kuhar M. J. (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237, 1219-1223.
58. Rivet J.-M., Audinot V., Gobert A., Peglion J.-L., and Millan M. J. (1994) Modulation of mesolimbic dopamine release by the selective dopamine D3 receptor antagonist, (+)-S 14297. Eur. J. Pharmacol. 265, 175-177.
59. Roberts D. C. S., Corcoran M. E., and Fibiger H. C. (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol. Biochem. Behav. 6, 615-620.
60. Roberts D. C. S., Koob G. F., Klonoff P., and Fibiger H. C. (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12, 781-787.
61. Robledo P. and Koob G. F. (1993) Two discrete nucleus accumbens projection areas differentially mediate cocaine self-administration in the rat. Behav. Brain Res. 55, 159-166.
62. Robledo P., Maldonado R., and Koob G. F. (1993) Neurotensin injected into the nucleus accumbens blocks the psychostimulant effects of cocaine but does not attenuate cocaine self-administration in the rat. Brain Res. 622, 105-112.
63. Sato K., Ueda H., Okumura F., and Misu Y. (1994) 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OH-DPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats. Brain Res. 655, 233-236.
64. Sautel F., Griffon N., Lévesque D., Pilon C., Schwartz J.-C., and Sokoloff P. (1995a) A functional test identifies dopamine agonists selective for D3 versus D2 receptors. Neuroreport 6, 329-332.
65. Sautel F., Griffon N., Sokoloff P., Schwartz J.-C., Launay C., Simon P., Costentin J., Schoenfelder A., Garrido F., Mann A., and Wermuth C. G. (1995b) Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents. J. Pharmacol. Exp. Ther. 275, 1239-1246.
66. Schwartz J.-C., Giros B., Martres M. P., and Sokoloff P. (1992) The dopamine receptor family: molecular biology and pharmacology. Semin. Neurosci. 4, 99-108.
67. Sibley D. R. and Monsma F. J. (1992) Molecular biology of dopamine receptors. Trends Pharmacol. Sci. 13, 61-65.
68. Sokoloff P., Giros B., Martres M. P., Bouthenet M. L., and Schwartz J.-C. (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347, 146-151.
69. Sokoloff P., Andrieux M., Besancon R., Pilon C., Martres M. P., Giros B., and Schwartz J.-C. (1992) Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur. J. Pharmacol. 225, 331-337.
70. Sugimoto T. and Mizuno N. (1987) Neurotensin in projection neurons of the striatum and nucleus accumbens, with reference to coexistence with enkephalin and GABA: an immunohistochemical study in the cat. J. Comp. Neurol. 257, 383-395.
71. Svensson K., Kling-Petersen T., Waters N., Ekman A., and Carlsson A. (1991) The preferential dopamine autoreceptor antagonist (+)-AJ76 increases motor activity in habituated rats and antagonizes d-amphetamine-induced hyperactivity. Post. Neurosci. 1, 75-79.
72. Tanaka T., Vincent S. R., Nomikos G. G., and Fibiger H. C. (1992) Effect of quinine on autoreceptor-regulated dopamine release in the rat striatum. J. Neurochem. 59, 1640-1645.
73. Tang L., Todd R. D., and O'Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270, 475-479.
74. Timmerman W., Tepper P. G., Dijkstriatuma D., Stoelwinder H., Grol C. J., Westerink B. H. C., and Horn A. S. (1991) Enantiomers of monohydroxy-2-aminotetralin derivatives and their activity at dopamine autoreceptors as studied by brain dialysis. Eur. J. Pharmacol. 199, 145-151.
75. Voorn P., Brady L. S., Schotte A., Berendse H. W., and Richfield E. K. (1994) Evidence for two neurochemical divisions in the human nucleus accumbens. Eur. J. Neurosci. 6, 1913-1916.
76. Wagstaff J. D., Bush L. G., Gibb J. W., and Hanson G. R. (1994) Endogenous neurotensin antagonizes methamphetamine-enhanced dopaminergic activity. Brain Res. 665, 237-244.
77. Waters N., Lagerkvist S., Löfberg L., Piercey M., and Carlsson A. (1993) The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study. Eur. J. Pharmacol. 242, 151-163.
78. Waters N., Hansson L., Löfberg L., and Carlsson A. (1994) Intracerebral infusion of (+)-AJ76 and (+)-UH232: effects on dopamine release and metabolism in vivo. Eur. J. Pharmacol. 251, 181-190.
79. Winger G. (1994) Dopamine antagonist effects on behavior maintained by cocaine and alfentanil in rhesus monkeys. Behav. Pharmacol. 5, 141-152.
80. Wise R. A. and Bozarth M. A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev. 94, 469-492.
81. Woods J. H., Winger G., and France C. P. (1987) Reinforcing and discriminative stimulus effects of cocaine: analysis and pharmacological mechanisms, in Cocaine: Clinical and Biobehavioral Aspects (Fisher S., Raskin A., and Uhlenhuth E. H., eds), pp. 21-65. Oxford University Press, New York.
82. Woolverton W. L. (1986) Effects of a D1 and a D2 dopamine antagonist on the self-administration of cocaine a piribedil by rhesus monkeys. Pharmacol. Biochem. Behav. 24, 531-535.
83. Woolverton W. L. and Virus R. M. (1989) The effects of a D1 and a D2 dopamine antagonist on behavior maintained by cocaine or food. Pharmacol. Biochem. Behav. 32, 691-697.
84. Yamada S., Yokoo H., and Nishi S. (1994) Differential effects of dopamine agonists on evoked dopamine release from slices of striatum and nucleus accumbens in rats. Brain Res. 648, 176-179.